NCT06970574

Brief Summary

Laparoscopy is one of the procedures of choice for most of the elective abdominal surgeries performed preferably under endotracheal general anesthesia. With the technical advances that have been made, laparoscopic cholecystectomy is considered a procedure with a good safety profile that offers advantages over open cholecystectomy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 10, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2023

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

May 6, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 14, 2025

Completed
Last Updated

May 14, 2025

Status Verified

July 1, 2022

Enrollment Period

12 months

First QC Date

May 6, 2025

Last Update Submit

May 6, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Effect of pneumoperitonum to shoulder pain

    Assessment of Intraoperative complaints of shoulder tip pain after carbon dioxide insufflation, using four grades \[0, no pain; 1, mild pain but no need for analgesic; 2, moderate pain and need for analgesic; 3, severe pain and no response to analgesics (need for conversion to general anesthesia)\]. And the severity will be observed using the 10 visual analogue scale where 0 meant no pain and 10 meant worst pain experience.

    from 0 hours to 6 hours after the procedure

Study Arms (2)

Group A

ACTIVE COMPARATOR

About 30 patients received 3.0 ml of heavy levo-bupivacaine with10 µg fentanyl (0.5 ml) to make 3.5 ml . All patients had been examined a day before surgery and will be kept fasting over-night, and received atropine 0.2 mg and ondansetron 8 mg intra venous as premedication. In the operation theater, patient's baseline pulse, blood pressure (BP), saturation, ETCO2, respiratory rate (RR), and electrocardiography (ECG) will be recordedand all will be preloaded with ringer lactate 15 ml/kg.

Drug: Levobupivacaine

Group B

ACTIVE COMPARATOR

About 30 patients received 3.0 ml of levo-bupivacaine along with dextmedetomidine 5 µg to make a total volume of 3.5 ml. All patients had been examined a day before surgery and will be kept fasting over-night, and received atropine 0.2 mg and ondansetron 8 mg intra venous as premedication. In the operation theater, patient's baseline pulse, blood pressure (BP), saturation, ETCO2, respiratory rate (RR), and electrocardiography (ECG) will be recordedand all will be preloaded with ringer lactate 15 ml/kg.

Drug: Levobupivacaine

Interventions

to compare the clinical intraoperative effects of intrathecal administration of fentanyl in comparison with dexmedetomidine on shoulder tip pain in patients undergoing laparoscopic cholecystectomy.

Also known as: fentanyl 50 mcg/ml, Dextmedetomidine
Group AGroup B

Eligibility Criteria

Age30 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • \- 60 patients aged from 30 to 60 years of either sex with American Society of Anesthesiologists (ASA) grades I and II undergoing Elective laparoscopic cholecystectomies.

You may not qualify if:

  • patients with ASA grade \>II,
  • Patients' refusal ,
  • Patients using α2-adrenergic receptors antagonists, calcium channel blockers,
  • angiotensin converting enzyme inhibitors ,
  • Dysrhythmia ,
  • Body weight more than 120 kg,
  • spinal deformity ,
  • History of allergy to the study drugs ,
  • Pregnancy ,
  • Coagulopathy ,
  • Neurological disorders
  • known contraindications to spinal anesthesia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag University Hospital

Sohag, Egypt

Location

MeSH Terms

Conditions

Cholecystitis

Interventions

LevobupivacaineFentanyl

Condition Hierarchy (Ancestors)

Gallbladder DiseasesBiliary Tract DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

BupivacaineAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Ahmed hamody Hassan, Assist. Prof.

    Anesthesiology, Intensive care, and Pain Management, Faculty of Medicine, Sohag University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Anesthesia, intensive care and pain management Faculty of Medicine

Study Record Dates

First Submitted

May 6, 2025

First Posted

May 14, 2025

Study Start

July 10, 2022

Primary Completion

July 1, 2023

Study Completion

July 10, 2023

Last Updated

May 14, 2025

Record last verified: 2022-07

Locations